Distalmotion

The company is led by CEO Michael Friedrich, a serial entrepreneur who joined as an investor and CEO. His leadership has been pivotal in navigating the company through its growth stages.

Distalmotion operates in the medical technology market, specifically focusing on surgical robotics. Its business model centers on selling its surgical robot, Dexter, to hospitals and surgical centers. The goal is to make robotic surgery more accessible by addressing common barriers such as complexity, cost, and workflow integration. The company serves surgeons and healthcare providers, aiming to improve the standard of care in procedures like general surgery, gynecology, and urology.

The Dexter surgical robot is designed to be easily integrated into existing laparoscopic workflows. Surgeons can operate from an ergonomic console, and the system allows for a seamless switch between robotic and laparoscopic techniques. This hybrid approach provides surgeons with the precision and dexterity of robotics while maintaining the flexibility and familiarity of traditional methods. The robot's open platform design and mobility are key features that differentiate it from other systems, allowing for on-demand robotic assistance without the need for a dedicated operating room.